Skip to main content
Erschienen in: European Radiology 12/2012

01.12.2012 | Breast

Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI

verfasst von: Valencia King, Yajia Gu, Jennifer B. Kaplan, Jennifer D. Brooks, Malcolm C. Pike, Elizabeth A Morris

Erschienen in: European Radiology | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the effect of menopausal status on the background parenchymal enhancement (BPE) and amount of fibroglandular tissue (FGT) on breast MRI.

Methods

Retrospective review identified 1,130 women who underwent screening breast MRI between July and November 2010. In 28 of these women, breast MRI was performed both at one time point while pre- and one time point while post-menopausal (median interval 49 months). Two independent readers blinded to menopausal status used categorical scales to rate BPE (minimal/mild/moderate/marked) and FGT (fatty/scattered/heterogeneously dense/dense). Consensus was reached when there was disagreement. The sign test was used to assess changes in rating categories, and the Spearman rank and Fisher’s exact tests were used to measure correlations and associations between variables.

Results

Significant proportions of women demonstrated decreases in BPE and FGT on post-menopausal breast MRI (P = 0.0001 and P = 0.0009). BPE category was unchanged in 39 % (11/28) and decreased in 61 % (17/28) of women. FGT category was unchanged in 61 % (17/28) and decreased in 39 % (11/28) of women. Age, reason for menopause, or interval between MRIs had no significant impact on changes in BPE and FGT.

Conclusion

On MRI, BPE, and FGT decrease after menopause in significant proportions of women; BPE decreases more than FGT.

Key Points

• On MRI, background parenchymal enhancement and fibroglandular tissue both decrease after menopause.
• The reduced postmenopausal enhancement is more marked in parenchyma than fibroglandular tissue.
• Background enhancement and fibroglandular tissue seen on MRI are under hormonal influence.
Literatur
1.
Zurück zum Zitat Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144PubMed Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144PubMed
2.
Zurück zum Zitat Morris EA (2007) Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 45:863–880PubMedCrossRef Morris EA (2007) Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 45:863–880PubMedCrossRef
3.
Zurück zum Zitat Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203:145–149PubMed Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203:145–149PubMed
4.
Zurück zum Zitat Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA (2011) Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol 196:218–224PubMedCrossRef Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA (2011) Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol 196:218–224PubMedCrossRef
5.
Zurück zum Zitat King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260:50–60PubMedCrossRef King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260:50–60PubMedCrossRef
6.
Zurück zum Zitat Hattangadi J, Park C, Rembert J et al (2008) Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol 190:1630–1636PubMedCrossRef Hattangadi J, Park C, Rembert J et al (2008) Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol 190:1630–1636PubMedCrossRef
7.
Zurück zum Zitat Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging - initial observations. Radiology 235:36–41PubMedCrossRef Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging - initial observations. Radiology 235:36–41PubMedCrossRef
8.
Zurück zum Zitat Pfleiderer SO, Sachse S, Sauner D et al (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 6:R232–238PubMedCrossRef Pfleiderer SO, Sachse S, Sauner D et al (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 6:R232–238PubMedCrossRef
9.
Zurück zum Zitat Eng-Wong J, Orzano-Birgani J, Chow CK et al (2008) Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomarkers Prev 17:1696–1701PubMedCrossRef Eng-Wong J, Orzano-Birgani J, Chow CK et al (2008) Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomarkers Prev 17:1696–1701PubMedCrossRef
10.
Zurück zum Zitat Oksa S, Parkkola R, Luukkaala T, Maenpaa J (2009) Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia. Acta Radiol 50:984–989PubMedCrossRef Oksa S, Parkkola R, Luukkaala T, Maenpaa J (2009) Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia. Acta Radiol 50:984–989PubMedCrossRef
11.
Zurück zum Zitat Sung JS, Lee CH, Morris EA, Oeffinger KC, Dershaw DD (2011) Screening breast MR imaging in women with a history of chest irradiation. Radiology 259:65–71PubMedCrossRef Sung JS, Lee CH, Morris EA, Oeffinger KC, Dershaw DD (2011) Screening breast MR imaging in women with a history of chest irradiation. Radiology 259:65–71PubMedCrossRef
12.
Zurück zum Zitat American College of Radiology BI-RADS Committee (2003) Breast Imaging Reporting and Data System, 4th edn. American College of Radiology, Reston, Virginia American College of Radiology BI-RADS Committee (2003) Breast Imaging Reporting and Data System, 4th edn. American College of Radiology, Reston, Virginia
13.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
14.
Zurück zum Zitat Jansen SA, Lin VC, Giger ML, Li H, Karczmar GS, Newstead GM (2011) Normal parenchymal enhancement patterns in women undergoing MR screening of the breast. Eur Radiol 21:1374–1382PubMedCrossRef Jansen SA, Lin VC, Giger ML, Li H, Karczmar GS, Newstead GM (2011) Normal parenchymal enhancement patterns in women undergoing MR screening of the breast. Eur Radiol 21:1374–1382PubMedCrossRef
15.
Zurück zum Zitat Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048–1053PubMed Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048–1053PubMed
Metadaten
Titel
Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI
verfasst von
Valencia King
Yajia Gu
Jennifer B. Kaplan
Jennifer D. Brooks
Malcolm C. Pike
Elizabeth A Morris
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 12/2012
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2553-8

Weitere Artikel der Ausgabe 12/2012

European Radiology 12/2012 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.